Home Application Market Business Products Research Strategic Partnerships Investor Relations Contact
Painkillers Anti-Histamine

Anti-Histamine

Asthma and allergies are among the most common ailments today. As much as 1 in 5 Americans suffer from mild allergies to cats, dust or pollen, and 7% of all Americans suffer from asthma. Asthma makes the throat constrict, in effect suffocating the person suffering from this ailment, eventually killing them if untreated. According to the New England Journal of Medicine, more than 300 million people suffer from asthma in the Western World.

Apart from the worst cases of asthma and allergies, which are treated by inhaling or injecting adrenocortical hormone in heavy doses, the common way to handle an allergic reaction is to take pills with antihistamines.

But if the patient is unable to swallow his medication, he or she will endure a very annoying allergic reaction. And unfortunately, being exposed to one untreated allergen will often lead to other allergies in the long run. For instance, a person suffering from an allergy to dust will over time become allergic to other allergens, such as cats, dogs, nickel, and certain types of food if the allergy towards dust remains untreated.

It is therefore imperative to be able to treat these allergens to avoid suffering from other allergies later on!

People unable to swallow their medication are therefore today restricted to either exposing themselves to allergens, or they have to isolate themselves from already existing allergens. And having an allergic or asthmatic reaction constricts the throat, making it even harder to receive the proper medication, making the risk of isolation even bigger! Having allergies towards cats, dogs or dust will literally isolate them from as much as 75% of their social circle.

Alterola Biotech is developing the solution for all of the allergic people, who are having a hard time swallowing their medication. As 20% of all people suffer from allergies, and as much as 40% of all American adults have difficulties swallowing their medication, Alterola is looking for a way to produce an Anti-Allergy Chewing gum that will benefit and improve the quality of life for millions of people in the US alone. The global market size for Alterola’s Anti-Allergy Chewing gum will be at least 100 million people.

"As much as 1 in 5 Americans suffer from mild allergies to cats, dust or pollen, and 7% of all Americans suffer from asthma."
[an error occurred while processing this directive]